COMBINED EFFECT OF VITAMIN B (B6, B9, B12) AND POTASSIUM SUPPLEMENTATION ON STROKE IN RAT MODEL

Main Article Content

Noman Aslam
Muhammad Imran Hussain
Khansa
Imran Nawaz Bhatti
Qaswara Affaf
Hafiza Iqra Akram
Sahir Shahzad
Tasbiha Irfan
Moha Akram Khan

Keywords

Vitamin B, Complete Blood Count (CBC), Homocysteine Level, Liver Function Tests (LFTs), Potassium

Abstract

Stroke is second most common cause of death and the third most common cause of disability worldwide. The burden of stroke is rising quickly in low and middle-income nations, many of which are ill-equipped to handle the problem it poses. The objective of the current study was to determine the combined effect of Vitamin B (B6, B9, B12) and Potassium supplementation on stroke in rat model. Methods:  Vitamin B (B6, B9, B12) and Potassium was bought in supplemented form. Rats were divided into five groups, including a control group Go). Complete Blood Count (CBC), Liver Function Test, Homocysteine Level and Blood Pressure were analyzed to check impact of B vitamins and potassium. The p-value <0.05 was considered significant. Results: Vitamin B (B6, B9, B12) and Potassium supplementations significantly decrease the Homocysteine level by 55% (19.95 ± 0.08 g/dL) and (21.97 ± 0.06 g/dL) respectively. The systolic and diastolic blood pressure significantly de-escalated with the potassium supplementation diastolic (84.96 ± 0.06 mmHg) and systolic (122.97 ± 0.06 mmHg) in (G4 group).  Conclusion: Our findings suggest that Vitamin B (B6, B9, B12) and Potassium supplementation shod improving trend in the CBC, LFT, s Homocysteine levels and BP. Further research is warranted to explore the translational potential in human subjects.

Abstract 67 | PDF Downloads 31

References

[1] Feigin, V. L., Stark, B. A., Johnson, C. O., Roth, G. A., Bisignano, C., Abady, G. G., Abbasifard, M., Abbasi-Kangevari, M., Abd-Allah, F., Abedi, V., Abualhasan, A., Abu-Rmeileh, N. M., Abushouk, A. I., Adebayo, O. M., Agarwal, G., Agasthi, P., Ahinkorah, B. O., Ahmad, S., Ahmadi, S., & Ahmed Salih, Y. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20(10), 795–820.
[2] Rolle-Lake, L., & Robbins, E. (2023). Behavioral Risk Factor Surveillance System. In StatPearls.
[3] GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
[4] Ovbiagele, B., Goldstein, L. B., Higashida, R. T., Howard, V. J., Johnston, S. C., Khavjou, O. A., Lackland, D. T., Lichtman, J. H., Mohl, S., Sacco, R. L., Saver, J. L., & Trogdon, J. G. (2013). Forecasting the Future of Stroke in the United States: A Policy
[5] Kuriakose, D., & Xiao, Z. (2020). Pathophysiology and Treatment of stroke: Present Status and Future Perspectives. International Journal of Molecular Sciences, 21(20), 7609
[6] Musuka, T. D., Wilton, S. B., Traboulsi, M., & Hill, M. D. (2015). Diagnosis and management of acute ischemic stroke: speed is critical. Canadian Medical Association Journal, 187(12), 887–893.
[7] Broughton, B. R. S., Reutens, D. C., & Sobey, C. G. (2009). Apoptotic Mechanisms After Cerebral Ischemia. Stroke, 40(5).
[8] Woodruff, T. M., Thundyil, J., Tang, S.-C., Sobey, C. G., Taylor, S. M., & Arumugam, T. V. (2011). Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Molecular Neurodegeneration, 6(1), 11.
[9] Hankey, G. J. (2018). B vitamins for stroke prevention. Stroke and Vascular Neurology, 3(2), 51–58.

[10] Costantini, A., Pala, M. I., Catalano, M. L., Notarangelo, C., & Careddu, P. (2014). High-Dose Thiamine Improves Fatigue After Stroke: A Report of Three Cases. The Journal of Alternative and Complementary Medicine, 20(9), 683–685.
[11] Guo, J., Lv, J., Guo, Y., Bian, Z., Zheng, B., Wu, M., Yang, L., Chen, Y., Su, J., Zhang, J., Yao, J., Chen, J., Chen, Z., Yu, C., & Li, L. (2021). Association between blood pressure categories and cardiovascular disease mortality in China. PLOS ONE, 16(7), e0255373.
[12] Zhao Y, Gu X, Sun X, Zhang Y, Gu J. The impact of potassium supplementation on stroke: A focus on stroke models and clinical trials. Nutrients. 2020;12(3):739.
[13] Qi, X., Sun, X., Xu, J., Wang, Z., Zhang, J., & Peng, Z. (2014). Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35(3), 1757–1762.
[14] França, C. F., & Vianna, L. M. (2010). Effectiveness of B vitamins on the control of hypertension and stroke events of SHRSP rats. Journal of dietary supplements, 7(1), 71–77.
[15] Hunt, B. D., & Cappuccio, F. P. (2014). Potassium intake and stroke risk: a review of the evidence and practical considerations for achieving a minimum target. Stroke, 45(5), 1519–1522.
[16] Li, Y., Huang, T., Zheng, Y., Muka, T., Troup, J., & Hu, F. B. (2016). Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 5(8), e003768.
[17] Park, J. H., Saposnik, G., Ovbiagele, B., Markovic, D., & Towfighi, A. (2016). Effect of B-vitamins on stroke risk among individuals with vascular disease who are not on antiplatelets: A meta-analysis. International journal of stroke : official journal of the International Stroke Society, 11(2), 206–211
[18] Homocysteine Studies Collaboration (2002). Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA, 288(16), 2015–2022.
[19] Spence, J. D., Yi, Q., & Hankey, G. J. (2017). B vitamins in stroke prevention: time to reconsider. The Lancet. Neurology, 16(9), 750–760
[20] Collaboration H. L. T. (1998). Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ (Clinical research ed.), 316(7135), 894–898.

Most read articles by the same author(s)